IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
552.22
-14.57 (-2.57%)
Jun 2, 2026, 12:54 PM EDT - Market open

IDEXX Laboratories Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, IDEXX Laboratories stock has a consensus rating of "Buy" and an average price target of $709.14. The average 1-year stock price forecast is 28.42% higher than the current stock price, while the lowest is $470 (-14.89%) and the highest is $805 (+45.78%).

Price Target: $709.14 (+28.42%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$470$709.14$712.5$805
Change-14.89%+28.42%+29.02%+45.78%

Analyst Ratings

The average analyst rating for IDEXX Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy555555
Buy444444
Hold555555
Sell000111
Strong Sell111000
Total151515151515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$675
BuyMaintains$675+22.23%May 6, 2026
Jefferies
Jefferies
Buy
Reiterates
$729
BuyReiterates$729+32.01%May 6, 2026
Morgan Stanley
Morgan Stanley
Buy
Reiterates
$765$805
BuyReiterates$765$805+45.78%May 6, 2026
Bank of America Securities
Bank of America Securities
Hold
Maintains
$790$660
HoldMaintains$790$660+19.52%May 5, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
4.71B
from 4.30B
Increased by 9.35%
Revenue Next Year
5.11B
from 4.71B
Increased by 8.66%
EPS This Year
14.67
from 13.08
Increased by 12.13%
EPS Next Year
16.54
from 14.67
Increased by 12.81%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
3.22B3.37B3.66B3.90B4.30B4.71B
Revenue Growth
18.80%4.73%8.72%6.46%10.42%9.35%
Gross Profit
1.89B2.00B2.19B2.38B2.66B2.94B
Gross Margin
58.76%59.52%59.82%61.04%61.80%62.40%
Operating Income
932.03M898.77M1.10B1.19B1.36B1.52B
Net Income
744.85M679.09M845.04M887.87M1.06B1.17B
EPS
8.608.0310.0610.6713.0814.67
EPS Growth
28.17%-6.63%25.28%6.06%22.59%12.13%
Forward PE
73.7744.2551.9335.3548.0337.65
Free Cash Flow
534.41M328.16M693.69M734.99M790.74M1.16B
No. Analysts
-----14

Revenue Forecast

Revenue202620272028
High4.7B
Avg4.7B
Low4.7B

Revenue Growth

Revenue Growth202620272028
High
9.9%
Avg
9.4%
Low
8.5%

EPS Forecast

EPS202620272028
High14.80
Avg14.67
Low14.52

EPS Growth

EPS Growth202620272028
High
13.1%
Avg
12.1%
Low
11.0%
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.